Michael Burgess actually said...

To me, diseases like muscular dystrophy are why the expedited approval pathways are so important.

Burgess advocates for expedited approval pathways for muscular dystrophy treatments.

05/19/2014

More Michael Burgess Quotes

something magic happens when people spend their own money.

But, sir, that is not new information. You said you have been working on this for 30 years. Where is the beef?

And I would just submit the obstacle so far has been CMS. They haven't been a facilitator; they have been an obstacle.

And not the IPAB and the provider.